Target intelligence / Profile preview

Filaggrin-2 (FLG2)

Target
FLG2
Molecular classification
Structural epidermal protein, S100 fused-type protein family
01

Overview

Filaggrin-2 is a large, S100 fused-type structural protein found in the granular keratinocytes of human skin, encoded by the *FLG2* gene[2]. Functionally, it is similar to filaggrin, mediating epidermal differentiation, cornification, and formation of the stratum corneum, which maintains the skin barrier. Filaggrin-2 undergoes proteolytic processing to provide free amino acids that contribute to natural moisturizing factors, regulate stratum corneum pH, and afford photoprotection. Mutations or reduced expression of *FLG2*, as seen in some atopic dermatitis patients, result in skin barrier impairment, increased sensitivity to UV radiation, abnormal cornification (parakeratosis), altered proteolytic processing of related proteins, and reduced quantities of protective amino acids[2]. Filaggrin-2's deficiency is linked to chronic skin diseases such as atopic dermatitis and persistent barrier dysfunction. It is one of several epidermal S100 fused-type proteins involved in skin health and disease.

Other names
Filaggrin-2FLG2IFPSFLG-2IfapsoriasinIntermediate filament-associated and psoriasis-susceptibility proteinPSS6filaggrin family member 2
02

Biological functions

CornificationSkin barrier formationRegulation of the stratum corneum pHContribution to the production of natural moisturizing factor componentsPhotoprotection of the epidermisKeratinocyte differentiation
03

Disease associations

Atopic dermatitisPsoriasisDry skin and impaired epidermal function

Beyond the preview

Go deeper on Filaggrin-2 (FLG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Filaggrin-2 (FLG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call